Raphaele Todaro, MD
Family Medicine · Wilmington, DENPI 1841245073
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for family medicine clinicians in DE, where the typical reported total is $306.
Across 17 payments — averaging $17.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$48
- Idorsia Pharmaceuticals US Inc$47
- Biohaven Pharmaceutical Holding Company Ltd.$35
- Novo Nordisk$32
- Tactile Systems Technology Inc$30
- Orexo US, Inc.$24
- plus $85 from 5 others
What the payments were for
- Food & beverage$303100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 3 | $48 |
| Idorsia Pharmaceuticals US Inc | 3 | $47 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $35 |
| Novo Nordisk | 2 | $32 |
| Tactile Systems Technology Inc | 1 | $30 |
| Orexo US, Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Indivior Inc. | 1 | $21 |
| Exact Sciences | 1 | $14 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
| Boehringer Ingelheim | 1 | $13 |
How this compares
$303 in reported general payments places this provider in the 45th percentile of 352 family medicine providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 20 | $2,194 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $512 |
| Oxycodone Hcl | 17 | $439 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $378 |
| Carisoprodol | 12 | $192 |
| Gabapentin | 15 | $177 |
| Tizanidine Hcl | 12 | $166 |
| Omeprazole | 11 | $112 |
| Clonazepam | 14 | $97 |
| Spironolactone | 13 | $96 |
| Diazepam | 12 | $74 |
| Zolpidem Tartrate | 15 | $63 |
| Alprazolam | 15 | $56 |
| Atorvastatin Calcium | 12 | $22 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Wilmington
- Sarah MullinsWilmington$36K
- Ashley PanichelliWilmington$27K
- Maryann ConnorWilmington$21K
- Jill MackeyWilmington$20K
- Glenn HamiltonWilmington$17K
- Lakan Karlo MagatWilmington$16K
- David KrasnerWilmington$16K
- Marc GrobmanWilmington$13K
- Julio NavarroWilmington$13K
- Anna MagatWilmington$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.